http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2616812-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_74487f7403edef60f9293ecb4f72065d
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S424-81
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S424-805
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-283
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-3955
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00
filingDate 2011-09-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_80f279c17195f5788029de9252538de4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f8fc0e7ed7c2452bbb913a679678900
publicationDate 2013-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-2616812-A1
titleOfInvention Methods of treating autoimmune diseases with anti-fceri antibodies
abstract Methods of using anti-FceRI or anti-lgE antibodies for treating an autoimmune disease are disclosed. Also disclosed is a composition comprising an anti-FceRI antibody or anti-IgE antibody for use in treating an autoimmune disease. Also disclosed are non-antibody compounds that specifically activate basophils and/or'mast cells, either by cross-linking IgE or FceRI, or by activating the cells through an FceRI-independent pathway and methods of using the same to treat autoimmune diseases.
priorityDate 2010-09-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003064063-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396799
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396800
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7813
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5366546
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393938
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393939
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3348
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7242
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226414691
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19777023
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57134040
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128492838
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4112
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226402551
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395835
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395836
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395375
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2756
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409442
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129205934
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6603853
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406078
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID126941

Total number of triples: 44.